Health
University of Sheffield spin-out Modulus Oncology to advance new drug targeting hard-to-treat cancers – GlobeNewswire
University of Sheffield spin-out Modulus Oncology to advance new drug targeting hard-to-treat cancers First-in-class drug blocks key signals required…
University of Sheffield spin-out Modulus Oncology to advance new drug targeting hard-to-treat cancers
- First-in-class drug blocks key signals required for tumour growth and metastasis
- Highly targeted so avoids damaging healthy cells potential for improved patient outcomes
- Modulus Oncology is currently in discussions for seed and series A investment
Sheffield, UK, 9 September 2020: Modulus Oncology, a new and rapidly emerging private biotech company focused on tr…
Continue Reading
-
Business18 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business21 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business17 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
General10 hours agoVictorian school teacher charged with soliciting child abuse material